AIM: To determine if antioxidant supplements (beta carotene and vitamins C and E) can decrease the progression of cataract in rural South India. METHODS: The Antioxidants in Prevention of Cataracts (APC) Study was a 5 year, randomised, triple masked, placebo controlled, field based clinical trial to assess the ability of interventional antioxidant supplements to slow cataract progression. The primary outcome variable was change in nuclear opalescence over time. Secondary outcome variables were cortical and posterior subcapsular opacities and nuclear colour changes; best corrected visual acuity change; myopic shift; and failure of treatment. Annual examinations were performed for each subject by three examiners, in a masked fashion. Multivariate modelling using a general estimating equation was used for analysis of results, correcting for multiple measurements over time. RESULTS:Initial enrolment was 798 subjects. Treatment groups were comparable at baseline. There was high compliance with follow up and study medications. There was progression in cataracts. There was no significant difference between placebo and active treatment groups for either the primary or secondary outcome variables. CONCLUSION:Antioxidant supplementation with beta carotene, vitamins C and E did not affect cataract progression in a population with a high prevalence of cataract whose diet is generally deficient in antioxidants.
RCT Entities:
AIM: To determine if antioxidant supplements (beta carotene and vitamins C and E) can decrease the progression of cataract in rural South India. METHODS: The Antioxidants in Prevention of Cataracts (APC) Study was a 5 year, randomised, triple masked, placebo controlled, field based clinical trial to assess the ability of interventional antioxidant supplements to slow cataract progression. The primary outcome variable was change in nuclear opalescence over time. Secondary outcome variables were cortical and posterior subcapsular opacities and nuclear colour changes; best corrected visual acuity change; myopic shift; and failure of treatment. Annual examinations were performed for each subject by three examiners, in a masked fashion. Multivariate modelling using a general estimating equation was used for analysis of results, correcting for multiple measurements over time. RESULTS: Initial enrolment was 798 subjects. Treatment groups were comparable at baseline. There was high compliance with follow up and study medications. There was progression in cataracts. There was no significant difference between placebo and active treatment groups for either the primary or secondary outcome variables. CONCLUSION: Antioxidant supplementation with beta carotene, vitamins C and E did not affect cataract progression in a population with a high prevalence of cataract whose diet is generally deficient in antioxidants.
Authors: J M Seddon; W G Christen; J E Manson; F S LaMotte; R J Glynn; J E Buring; C H Hennekens Journal: Am J Public Health Date: 1994-05 Impact factor: 9.308
Authors: Praveen K Nirmalan; Ramasamy Krishnadas; Rengappa Ramakrishnan; Ravilla D Thulasiraj; Joanne Katz; James M Tielsch; Alan L Robin Journal: Invest Ophthalmol Vis Sci Date: 2003-11 Impact factor: 4.799
Authors: Yuliya V Rumyantseva; Elena I Ryabchikova; Anjela Z Fursova; Nataliya G Kolosova Journal: Graefes Arch Clin Exp Ophthalmol Date: 2014-09-30 Impact factor: 3.117
Authors: L V Yanshole; V V Yanshole; O A Snytnikova; A Zh Fursova; N G Kolosova; Yu P Tsentalovich; R Z Sagdeev Journal: Dokl Biochem Biophys Date: 2015-10-31 Impact factor: 0.788
Authors: William G Christen; Robert J Glynn; Emily Y Chew; Christine M Albert; JoAnn E Manson Journal: Ophthalmic Epidemiol Date: 2016-01-20 Impact factor: 1.648
Authors: William G Christen; Robert J Glynn; Joann E Manson; Jean MacFadyen; Vadim Bubes; Miriam Schvartz; Julie E Buring; Howard D Sesso; J Michael Gaziano Journal: Ophthalmology Date: 2013-11-20 Impact factor: 12.079